Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL153408 | 0.84 | FDPS (0.36) | TSHRSMN1; SMN2 | |
| SCHEMBL1702605 | 0.74 | ALDH1A1 (0.33) | — | |
| Vinyl Ether SCHEMBL18260266 | 0.73 | — | — | |
| SCHEMBL7042679 | 0.71 | TSHR (0.38) | TSHR | |
| SCHEMBL18260265 | 0.70 | TSHR (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL532845 | 0.70 | FDPS (0.35) | TSHRSMN1; SMN2 | |
| SCHEMBL17559998 | 0.70 | FDPS (0.35) | TSHRSMN1; SMN2 | |
| 2-Ethylhexanoic Acid SCHEMBL4669801 | 0.69 | CA2 (0.67) | SMN1; SMN2 | |
| Acetoacetic Acid SCHEMBL8999866 | 0.69 | CA2 (0.35) | — | |
| Hexane SCHEMBL27490692 | 0.69 | TSHR (0.43) | TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10423084-B2 | Method for producing liquid developer | CANON KABUSHIKI KAISHA (JP) | 2019-09-24 | — | — | US | disclosed |
| US-20190155180-A1 | METHOD FOR PRODUCING LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2019-05-23 | — | — | US | disclosed |
| US-20180046102-A1 | LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2018-02-15 | — | — | US | disclosed |
| US-9891546-B2 | Ultraviolet-curable liquid developer | CANON KABUSHIKI KAISHA (JP) | 2018-02-13 | — | — | US | disclosed |
| US-20160349651-A1 | ULTRAVIOLET-CURABLE LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2016-12-01 | — | — | US | disclosed |